Managing blood sugar levels has become increasingly crucial for overall health and well-being in today's fast-paced world.
Agios Pharmaceuticals, Inc. (AGIO), on Wednesday, announced that its supplemental New Drug Application seeking approval for the ...
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced that the U.S. Food and Drug Administration (FDA) has accepted an ...
Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...
On December 5, 2024, the U.S. Food and Drug Administration (FDA or Agency) issued a draft guidance entitled Expedited Program for ...
OpenAI CEO Altman, 39, and Amazon founder Bezos, 60, have shelled out millions in recent years to longevity labs Retro ...
This is the second volume of the Research Topic titled 'Novel Insights into CAR T-cell Associated Neurotoxicity'. You may ...
Learn about clinical trials, from preclinical studies to Phase IV trials. Explore the different clinical trial phases (I-III) ...
Indian medical device manufacturers are enhancing GMP compliance and embracing proactive strategies to meet rising USFDA ...
The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...
The Percheron Therapeutics (ASX:PER) board of directors has written a letter to shareholders following failure of its phase 2b trial of lead candidate avicursen (ATL-1102) into non-ambulant (unable to ...